Clinical Validation of a New Algorithm for Computerized Dosing of Vitamin K Antagonist Therapy

N/ACompletedNCT01392040

University Of Perugia100 enrolled

Overview

The purpose of this study is to determine whether the new algorithm is safety and effective in proposing the dosage and the timing of oral anticoagulant therapy.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Anticoagulated Patients

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * to take oral anticoagulant therapy for at least 2 years * to be in stable conditions for at last 3 months Exclusion Criteria: * patients who need to perform surgery * patients who interrupt therapy

Locations (1)

Hospital of Macerata

Macerata, Macerata, Italy

Outcomes

Primary Outcomes

Time spent in therapeutic range of INR by the patients

Time frame: 6 months

Secondary Outcomes

Thrombotic and bleeding events

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.